Volitionrx Ltd (VNRX) is a Healthcare · Medical Devices company listed on NYSE MKT. Price $0.26 (-8.28%), Market cap $0.02B, 52-week low–high $0.14 ~ $2.78.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for earl
Financial statements, price targets, institutional (13F) holdings and related news for Volitionrx Ltd are updated in real time on BlackAll Trade.
Volitionrx Ltd trades at $0.26 (-8.28%). Real-time quotes and charts are available on BlackAll Trade.
Volitionrx Ltd has a market cap of about $0.02B.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asi